The production, distribution, possession and import of various drugs and substances in Canada are governed by the provisions of the Controlled Drugs and Substances Act (CDSA). Controlled Canada drugs and substances for medical treatment can be legally obtained only with a prescription from a licensed medical practitioner. Also, a prescription drug can be legally possessed and used only by the person for whom it has been prescribed. A person convicted of trafficking or unlawful possession, export, import, trade or production of such drugs may have to face imprisonment or fine or both in some cases. The safe manufacturing and storing of Canada drugs is covered under the drugs section of the Food and Drugs Act of Canada.
Role of Health Canada in Governing Canada Drugs
Health Canada is the leading organization regulating pharmaceutical companies and advertisers of Canada drugs since 1996. The organization plays a major role in governing the manufacture and sale of Canada drug in various ways:
A pharmaceutical company seeking to sell a prescription or an over-the-counter drug in Canadian stores or online pharmacies must seek a Notice of Compliance (NOC) from Health Canada. This NOIC is issued after the company fulfils certain criteria, like informing Health Canada officials of adverse drug reactions from clinical trials and developing a production process for maintaining drug quality.
Health Canada reviews products at various points in their development process.
Every drug developer in Canada has to seek a clinical trial application from Health Canada before testing any drug on the Canadian public. Once the trial is complete, government officials conduct a review to assess the research reports and determine irregularities, if any.
Health Canada offers product labeling standards
Health Canada's MedEffect Program is used to report adverse reactions to any of the approved Canada drugs.
Categories of Canada Drugs
Health Canada divides potential Canada drugs or drugs undergoing clinical trials and submission review into two categories. Category one refers to old drugs and covers non-prescription painkillers, medicines for cough or other products that are already available in the market. Category two of new drugs includes prescription drugs like diet pills, contraceptives or drugs for the treatment of serious diseases. This category of drugs requires greater scrutiny. Health Canada's MedEffect program involves the publishing of details about product recalls, adverse reaction warnings and educational information for consumers about drugs consumed by them. Consumers and healthcare experts can inform Health Canada of drugs that had severe side effects.
Role of Health Canada in Governing Canada Drugs
Health Canada is the leading organization regulating pharmaceutical companies and advertisers of Canada drugs since 1996. The organization plays a major role in governing the manufacture and sale of Canada drug in various ways:
A pharmaceutical company seeking to sell a prescription or an over-the-counter drug in Canadian stores or online pharmacies must seek a Notice of Compliance (NOC) from Health Canada. This NOIC is issued after the company fulfils certain criteria, like informing Health Canada officials of adverse drug reactions from clinical trials and developing a production process for maintaining drug quality.
Health Canada reviews products at various points in their development process.
Every drug developer in Canada has to seek a clinical trial application from Health Canada before testing any drug on the Canadian public. Once the trial is complete, government officials conduct a review to assess the research reports and determine irregularities, if any.
Health Canada offers product labeling standards
Health Canada's MedEffect Program is used to report adverse reactions to any of the approved Canada drugs.
Categories of Canada Drugs
Health Canada divides potential Canada drugs or drugs undergoing clinical trials and submission review into two categories. Category one refers to old drugs and covers non-prescription painkillers, medicines for cough or other products that are already available in the market. Category two of new drugs includes prescription drugs like diet pills, contraceptives or drugs for the treatment of serious diseases. This category of drugs requires greater scrutiny. Health Canada's MedEffect program involves the publishing of details about product recalls, adverse reaction warnings and educational information for consumers about drugs consumed by them. Consumers and healthcare experts can inform Health Canada of drugs that had severe side effects.